Mesenchymal Stem Cell Approach Meets End Points in Placebo-Controlled Trial of Parkinson Disease
A recently published phase 2 randomized, placebo-controlled trial demonstrated that three infusions of 10 × 10⁶ allogeneic human…
Browsing Tag